Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
182,917,028
-
Total 13F shares
-
22,225,342
-
Share change
-
+1,570,502
-
Total reported value
-
$780,113,100
-
Price per share
-
$35.10
-
Number of holders
-
72
-
Value change
-
+$59,933,498
-
Number of buys
-
38
-
Number of sells
-
32
Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q4 2017
As of 31 Dec 2017,
Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,225,342 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, EcoR1 Capital, LLC, BlackRock Inc., BB BIOTECH AG, JANUS HENDERSON GROUP PLC, PERCEPTIVE ADVISORS LLC, and Boxer Capital, LLC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.